Pernille Lassen

6PUBLICATIONS
22CO-AUTHORS
Predictive and prognostic markersSocial epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 27, 2025
Mutational profile of oropharyngeal squamous cell carcinoma in relation to HPV, tobacco smoking and prognosis with validation in the DAHANCA 19 randomized trial.

Jacob Lilja-Fischer, Morten Horsholt Kristensen, Pernille Lassen

|Aug 15, 2025
Subsite variation of HPV-related p16-expression in oropharynx cancer: Incidence and prognostic impact in a population-based DAHANCA cohort 1986-2020.

Pernille Lassen, Jan Alsner, Hanne Primdahl

|Oct 14, 2023
HPV testing versus p16 immunohistochemistry in oropharyngeal squamous cell carcinoma: results from the DAHANCA 19 study.

Jacob Kinggaard Lilja-Fischer, Morten Horsholt Kristensen, Pernille Lassen

|Sep 06, 2023
Socioeconomic position and the pre-diagnostic interval among patients diagnosed with head and neck squamous cell carcinoma - a population-based study from DAHANCA.

Maja Halgren Olsen, Thomas Maltesen, Pernille Lassen

|Nov 18, 2021
Treatment outcomes and survival following definitive (chemo)radiotherapy in HPV-positive oropharynx cancer: Large-scale comparison of DAHANCA vs PMH cohorts.

Pernille Lassen, Shao Hui Huang, Jie Su

|Feb 15, 2021
Correlation and prognostic impact of human papilloma virus and p16-expression in advanced hypopharynx and larynx cancer treated with definitive radiotherapy.

Pernille Lassen, Marie Schou, Jens Overgaard

Pageof 1

Frequent Collaborators

5 joint publications

Jens Overgaard

4 joint publications

Jan Alsner

4 joint publications

Jørgen Johansen

4 joint publications

Hanne Primdahl